Jeremy Graff

Jeremy Graff

Chairman at IN8BIO, INC.

Net worth: 41 087 $ as of 31/05/2026

56 year
Commercial Services
Health Technology
Consumer Services

Profile

Jeremy R.
Graff
is currently Chairman at IN8bio, Inc. starting in 2026, Trustee at Wood Hudson Cancer Research Laboratory, Inc., and President & Chief Development Officer at Allarity Therapeutics, Inc. beginning in 2024.
Former roles include Chief Scientific Officer at IMV, Inc. from 2021 to 2024, Chief Development Officer & Senior VP-Research at HiberCell, Inc. from 2020 to 2021, and President & Chief Scientific Officer at Biothera Pharmaceuticals, Inc. (Delaware) from 2018 to 2020 as well as at Biothera, Inc. Education includes undergraduate studies at Thomas More University and a doctorate from the University of Kentucky.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
29/04/2026 24,881 ( 0.16% ) 40 805 $ 31/05/2026
09/05/2026 151 ( 0% ) 282 $ 31/05/2026

Jeremy Graff active positions

CompaniesPositionStart
IN8BIO, INC. Chairman 28/02/2026
ALLARITY THERAPEUTICS, INC. President 03/10/2024
Director/Board Member -

Former positions of Jeremy Graff

CompaniesPositionEnd
IMV INC. Chief Tech/Sci/R&D Officer 01/01/2024
Chief Tech/Sci/R&D Officer 01/03/2021
President 01/06/2020
President 01/06/2020
See the detail of Jeremy Graff's experience

Training of Jeremy Graff

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

15

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Commercial Services

Consumer Services

Consumer Services

Health Technology

Health Services

Health Technology

Commercial Services

Health Technology

Commercial Services

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!